Norris Medicines Ltd.
BSE: 524414 | Sector: Others |
NSE: N.A. | ISIN Code: INE744C01029 |
BSE 00:00 | 12 Aug | 10.48 |
0.09 (0.87%) |
OPEN
10.49 |
HIGH
10.49 |
LOW
9.90 |
NSE 05:30 | 01 Jan | Norris Medicines Ltd |
OPEN | 10.49 |
PREVIOUS CLOSE | 10.39 |
VOLUME | 86 |
52-Week high | 36.75 |
52-Week low | 7.85 |
P/E | |
Mkt Cap.(Rs cr) | 10 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Norris Medicines Ltd. (NORRISMEDICINES) - Financial Ratios
Ratios | 2021 | 2020 | 2019 |
Debt-Equity Ratio | 0.00 | 0.00 | 7.80 |
Current Ratio | 0.44 | 0.50 | 0.66 |
Asset turnover ratio | 0.44 | 0.28 | 0.59 |
Inventory turnover ratio | 2.69 | 2.03 | 3.97 |
Debtors turnover ratio | 5.38 | 2.74 | 5.96 |
Interest Coverage ratio | -1.45 | -3.18 | -1.75 |
Operating Margin (%) | -13.88 | -26.20 | -3.49 |
Net Profit Margin (%) | -40.49 | -35.95 | -10.28 |
Return on Capital Employed (%) | 0.00 | 0.00 | 0.00 |
Return on Net Worth (%) | 0.00 | 0.00 | 0.00 |
Quick Links for Norris Medicines:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices